GlassScriptPhysician profile
Geneva Ann Green
NPI 1114533072
$2,376.62
in general payments reported to CMS, 2019-2025
22 companies · $648 in 2025
The $648 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,001 · 2022: $218 · 2023: $288 · 2024: $222 · 2025: $648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092 · Travel and Lodging: $65.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.06 |
| Travel and Lodging | $65.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,145.50 | 2021-2025 | |
| Galderma Laboratories, L.P. | $248.67 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.89 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $101.83 | 2021 | |
| Glaxosmithkline, LLC. | $91.74 | 2021-2023 | Arexvy |
| Novo Nordisk INC | $82.04 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $78.25 | 2021 | |
| Janssen Pharmaceuticals, INC | $75.88 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $62.96 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $50.82 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $43.99 | 2021 | |
| Organon LLC | $36.90 | 2021 | |
| Mentor Worldwide LLC | $33.42 | 2022-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Integra Lifesciences Corporation | $31.95 | 2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Esperion Therapeutics, INC. | $31.56 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $27.54 | 2021 | |
| Motiva USA, LLC | $22.46 | 2024 | |
| Bausch Health US, LLC | $20.94 | 2022 | |
| Lilly USA, LLC | $20.70 | 2022 | |
| Eisai INC. | $17.71 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $17.54 | 2021 | |
| Pfizer INC. | $17.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geneva Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.